RTP pharma firm could get $45M if therapy targeting hearing lose due to chemo wins FDA OK
Triangle-based Fennec Pharmaceuticials has a lot riding on possible FDA approval of its new drug candidate – Pedmark. Up to $45 million, in fact.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
